Special articleAlopecia areata investigational assessment guidelines–Part II☆
Section snippets
Discussion
The literature is replete with small studies on alopecia areata that are not able to be directly compared due to either endpoints that are non-quantitative, poorly defined or which were unnecessarily linked to the sites of hair loss and the sites of regrowth.2., 3., 4., 5., 6., 7., 8., 9., 10., 11., 12., 13., 14. For example, the term “cosmetically acceptable” has been a commonly utilized term that unduly weighs improvement in the top relative to the sides of the scalp since growth here can
References (14)
- et al.
Alopecia areata investigational assessment guidelines
J Am Acad Dermatol
(1999) - et al.
A randomized double-blind study of Inosiplex (isoprinosine) therapy in patients with alopecia totalis
J Am Acad Dermatol
(1987) Oral cyclosporine for the treatment of alopecia areata: A clinical and immunohistochemical analysis
J Am Acad Dermatol
(1990)Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata
J Am Acad Dermatol
(1987)- et al.
Therapeutic experiments in alopecia areata with orally administered cortisone
JAMA
(1952) - et al.
Alopecia areata: Immunologic studies and treatment with prednisone
Arch Dermatol
(1973) Treatment of alopecia areata with Kromayer's ultraviolet lamp
Acta Derm Venereol (Stockh)
(1961)
There are more references available in the full text version of this article.
Cited by (0)
- ☆
Funding sources: None.
Conflicts of interest: None identified.
Copyright © 2004 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.